GL Biochem (Shanghai): difference between revisions
Diff·revision 31 → 32·19:42, 27 Nov 2024
Difference between revision 31 and revision 32 of GL Biochem (Shanghai). 7 lines changed; the page grew by 144 bytes.
| Revision 31 — 17:02, 20 Nov 2024 SafetySignalSid (talk) expand §External links 7,641 bytes +284 | Revision 32 — 19:42, 27 Nov 2024 CheckSumChase (talk) attribute range as a review estimate per talk 7,785 bytes +144 | ||
|---|---|---|---|
| 61 | <ref name="gmp">World Health Organization, ''Good Manufacturing Practices for Pharmaceutical Products: Main Principles'', WHO Technical Report Series. The general framework against which a GMP claim is assessed.</ref> | 61 | <ref name="gmp">World Health Organization, ''Good Manufacturing Practices for Pharmaceutical Products: Main Principles'', WHO Technical Report Series. The general framework against which a GMP claim is assessed.</ref> |
| 62 | 62 | ||
| + | 63 | == See also == | |
| + | 64 | * [[Certificate of analysis]] | |
| + | 65 | * [[Third-party testing]] | |
| + | 66 | * [[Area percent purity]] | |
| + | 67 | * [[Peptide content]] | |
| + | 68 | * [[Research use only]] | |
| + | 69 | ||
| 63 | {{DEFAULTSORT:GL Biochem (Shanghai)}} | 70 | {{DEFAULTSORT:GL Biochem (Shanghai)}} |
| 64 | [[Category:Peptide suppliers]] | 71 | [[Category:Peptide suppliers]] |